Researchers in this study wanted to understand the earliest changes that happen in breast cells before cancer fully develops. While many studies focus on advanced tumors, this research looked at changes that occur in normal breast tissue and early-stage transformation, with the goal of identifying markers that could signal increased cancer risk.
The researchers focused on a gene called FAM83A, which has been linked to cancer in previous studies. They examined breast tissue samples from both healthy women and breast cancer patients and also performed laboratory experiments using normal breast cells. By increasing or decreasing FAM83A levels in these cells, they were able to observe how it affected cell behavior.
They found that FAM83A levels were higher in breast cancer tissue compared to normal tissue. In laboratory experiments, increasing FAM83A caused normal breast cells to grow faster and survive longer, which are early features of cancer development. It also changed how cells process energy and regulate important biological pathways linked to cancer.
Overall, the study suggests that FAM83A plays an important role in the early stages of breast cancer development and could serve as a marker to identify individuals at higher risk.
